VC firms
Vives
Edit

Vives

https://vivesfund.com
Last activity: 29.05.2026
Active
Vives is an interregional seed and early stage technology multi-sector fund dedicated to creating sizeable value by building and investing in world class technology based companies with a view to supporting their growth and innovation activities, with a special focus on Eco-innovation.
Sopartec, the managing company of Vives II, is the technology transfer company of UCL. Sopartec has been entrusted with the management of the intellectual property of UCL and its commercialisation through licenses, partnerships and the creation of new companies. Sopartec is a member of the Louvain Technology Transfer Office ("LTTO"​) together with the Research Department ("ADRE"​) of UCL and Sopartec has founded with some of the Initial Shareholders, and manages, the VIVES I Fund
Mentions
13

Overview

Location
Belgium, Walloon Brabant, Louvain-la-Neuve
Employees
1-10
Founded date
2004
Investment Type
Venture Capital
Investment Stage
Pre-Seed; Seed; Series A

Funds raised 1

DateFund sizeAnnouncement
Sign up to seeSign up to seeSign up to see

Mentions in press and media 13

DateTitleDescription
Sign up to seeSign up to seeSign up to see
Oct 1, 2025Sunrise Group: $29 Million Raised For Expanding Dreem HealthSunrise Group, known as a leader in sleep health technology, has announced a funding round of $29 million dedicated to expanding Dreem Health, its innovative digital sleep clinic, to ensure its services reach all 50 states in the U.S. This ...
Sep 25, 2025Sunrise Group Raises $29M to Expand Dreem Health and Build the Largest U.S. Sleep ClinicWhat You Should Know: –Sunrise Group, a leader in sleep health technology, today announced a $29 million funding round to expand Dreem Health, its digital sleep clinic, across all 50 states. – The round was led by Eurazeo, with participatio...
Jul 10, 2025CHF 79 million to advance Nuclidium’s copper-based radiopharmaceutical platform NUCLIDIUM’s differentiated platform links tumor-targeting molecules with copper isotopes – Copper-61 for diagnostics and Copper-67 for therapeutics – to address current limitations in radiotheranostics, such as suboptimal clinical efficacy...
May 14, 2025Aphea.Bio: Cultivating the Future of Sustainable AgricultureIn the heart of Belgium, a revolution is brewing. Aphea.Bio, an agricultural technology company, is leading the charge toward a greener future. With a recent €70 million Series C funding round, the company is poised to transform the agricul...
Sep 9, 2024Belgium-based VIVES IUF Fund raises additional €5 million to invest in Luxembourg startupsVIVES Inter-University Fund (IUF), a European science based early-stage fund, announced the securing of an additional €5 million from the Luxembourg Future Fund 2 (LFF 2), bringing its total funding to €75 million. LFF 2 is a €200 million i...
Jan 30, 2024VIVES IUF raises €70M to fund 10 science-based venturesToday VIVES IUF (inter-university fund), a European high-tech early-stage fund, announced that it has raised €38 million in capital, bringing its total funding to €70 million. The European Investment Fund (EIF) committed €25 million alongsi...
Jan 30, 2024VIVES IUF Fund Secures €70M Equity to Catalyze Science into StartupsVIVES, a Louvain-la-Neuve, Belgium-based high-tech early-stage firm, raised €38M ($41.3M) in the second closing of VIVES IUF, bringing total funding to €70M ($76M). The European Investment Fund (EIF), a current shareholder in VIVES I (€15M ...
Mar 10, 2023Belgium-based Sunrise bags €17M to help people suffering from sleep disordersBelgium-based Sunrise, a healthtech company that claims to be revolutionising sleep analysis, announced on Thursday, March 9, that it has raised €17M in a fresh round of funding. This funding is in addition to €12M that the startup has alre...
Dec 21, 2021Aphea.bio closes its Series B round and raises € 18M in totalGent, Belgium, April 14th, 2021 - The European Circular Bioeconomy Fund (ECBF) announces today its equity investment in Aphea.Bio, which thereby brings its Series B financing to a total of EUR 18 million. Aphea.Bio develops a new generation...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In

FAQ about Vives

When was Vives founded?

Vives was founded in 2004.

What funds has Vives raised?

Vives has announced 1 fund on Parsers VC.

What has the press written about Vives?

Parsers VC has collected 13 articles mentioning Vives, among them “Sunrise Group: $29 Million Raised For Expanding Dreem Health” (Oct 1, 2025) and “Sunrise Group Raises $29M to Expand Dreem Health and Build the Largest U.S. Sleep Clinic” (Sep 25, 2025).

Is Vives still active?

Yes, Vives is active; its latest activity on Parsers VC dates from May 29, 2026.